Noortje van Gils

MSC.

20162018
If you made any changes in Pure these will be visible here soon.

Research Output 2016 2018

  • 6 Article
  • 3 Meeting Abstract
  • 1 Review article
Filter
Article
2018

Abstract 1114: IGFBP7 reduces acute myeloid leukemia stem cell survival without affecting normal hematopoiesis

Cil, M., Vermue, E., Zweegman, S., Smit, M., Schuurhuis, G. J., Klootwijk, L. L. D. V., Menezes, R. X., Tsui, M-L., Smit, L., Rutten, A., Gils, N. V., Brocco, F., Roemer, M. G., Ossenkoppele, G. J., Verhagen, H. J., Rhenen, A. V., Janssen, J. J., Denkers, F. & Heukelom, S., 17 Aug 2018, In : Cancer Research. 78, 13 Supplement, p. 1114-1114 1 p.

Research output: Contribution to journalArticleAcademicpeer-review

IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis

Verhagen, H. J. M. P., van Gils, N., Martiañez, T., van Rhenen, A., Rutten, A., Denkers, F., de Leeuw, D. C., Smit, M. A., Tsui, M-L., de Vos Klootwijk, L. L. E., Menezes, R. X., Çil, M., Roemer, M. G. M., Vermue, E., Heukelom, S., Zweegman, S., Janssen, J. J. W. M., Ossenkoppele, G. J., Schuurhuis, G. J. & Smit, L., 11 Dec 2018, In : Cell Reports. 25, 11, p. 3021-3035.e5

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
2017

Cannabinoid CB receptor ligand profiling reveals biased signalling and off-target activity

Soethoudt, M., Grether, U., Fingerle, J., Grim, T. W., Fezza, F., de Petrocellis, L., Ullmer, C., Rothenhäusler, B., Perret, C., van Gils, N., Finlay, D., MacDonald, C., Chicca, A., Gens, M. D., Stuart, J., de Vries, H., Mastrangelo, N., Xia, L., Alachouzos, G., Baggelaar, M. P. & 12 othersMartella, A., Mock, E. D., Deng, H., Heitman, L. H., Connor, M., Di Marzo, V., Gertsch, J., Lichtman, A. H., Maccarrone, M., Pacher, P., Glass, M. & van der Stelt, M., 3 Jan 2017, In : Nature Communications. 8, p. 13958

Research output: Contribution to journalArticleAcademicpeer-review

Structural basis of ligand interaction with atypical chemokine receptor 3

Gustavsson, M., Wang, L., van Gils, N., Stephens, B. S., Zhang, P., Schall, T. J., Yang, S., Abagyan, R., Chance, M. R., Kufareva, I. & Handel, T. M., 18 Jan 2017, In : Nature Communications. 8, p. 14135

Research output: Contribution to journalArticleAcademicpeer-review

2016

Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors

Soethoudt, M., van Gils, N., van der Stelt, M. & Heitman, L. H., 2016, In : Methods in Molecular Biology. 1412, p. 103-11 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity

Mukhopadhyay, P., Baggelaar, M., Erdelyi, K., Cao, Z., Cinar, R., Fezza, F., Ignatowska-Janlowska, B., Wilkerson, J., van Gils, N., Hansen, T., Ruben, M., Soethoudt, M., Heitman, L., Kunos, G., Maccarrone, M., Lichtman, A., Pacher, P. & Van der Stelt, M., Feb 2016, In : British Journal of Pharmacology. 173, 3, p. 446-58 13 p.

Research output: Contribution to journalArticleAcademicpeer-review